Assets that tend to move strongly with SGRY
Assets with little price relationship to SGRY
Assets that tend to move strongly against SGRY
Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.
Most Recent SGRY News
Especially vulnerable are older patients with probable dementia (33% die within a year) and frailty (28%), as well as those having emergency surgeries (22%). Advanced age also amplifies risk: Patients who were 90 or older were six times as likely to die than those ages 65 to 69.
— CNN (November 27) (Pocket)
The layoffs are piling up. I speculate that more will follow. If you have been recently fired, you’re not alone. I understand how you feel — at minimum, it can be emotionally and financially derailing. But after every concluded chapter, there’s a new one, and I will help you make an informed decision about why you should consider a cooperative for your next thing. Another alternative is the startup treadmill which can be stressful, but what if you can have the same founder-level control without the usual baggage of the startup world with some benefits from the corporate world?
— Medium (November 28) (Pocket)
Meir Ayash was the security coordinator responsible for various outposts surrounding the central West Bank settlement of Shiloh. His removal centers on leaking sensitive army information to far-right activists over the course of the last several months, according to sources in the army. The sources added that the information on which the decision to remove Ayash was predicated on came mostly from the Shin Bet.
— Haaretz (November 27) (Pocket)
Musk indicated that the death of his firstborn son had informed his decision not to reinstate the account of Jones, whose known for spreading conspiracy theories about school shootings.
— South China Morning Post (November 22) (Pocket)
The Federal Communications Commission has finally published new broadband maps after a protracted development process. The "pre-production draft" release, as the FCC describes it, promises much more accurate representations of fixed internet coverage across the US. Earlier maps would only show service at the census block level, sometimes ignoring large gaps in real-world connectivity. The new maps are accurate enough that you can search by address to see which carriers are available, including the maximum claimed speeds.The updated maps could help would-be subscribers make more informed choices about broadband service, the FCC says. They'll also theoretically add "market pressures" to internet providers who may have considered an area served if just one home in a census block ...
— Engadget (November 22) (Pocket)
A framework for calculating the cost of circulating tumor DNA testing across different workflows is presented in the Journal of Molecular Diagnostics this week, providing a tool that can help labs and hospitals make informed investment decisions. As ctDNA testing becomes increasingly used in cancer care, estimating its total cost — a requirement for reimbursement and implementation — remains challenging due to variations in workflows. To help overcome this problem, researchers from the Netherlands Cancer Institute developed a framework that provides a consistent total cost calculation for ctDNA testing across different diagnostic workflows and platforms — including aspects such as personnel, materials, overhead, and failures — while taking test volume into account.
— Genome Web (November 18) (Pocket)
NICE has recommended three drugs—nirmatrelvir plus ritonavir (Paxlovid), tocilizumab (RoActemra), and baricitinib (Olumiant)—for the treatment of covid-19 in adults, as part of draft guidance.1The review of the efficacy and cost effectiveness of drugs currently being used in the NHS to treat covid-19 considered treatments in the context of routine commissioning, rather than their use in exceptional circumstances, such as during a pandemic.NICE has not recommended other covid-19 treatments, including casirivimab plus imdevimab (Ronapreve), molnupiravir (Lagevrio), remdesivir (Veklury), sotrovimab (Xevudy), and tixagevimab plus cilgavimab (Evusheld).Currently, access to covid-19 drugs is guided by the UK wide clinical access policies agreed by the UK chief medical officers.
— BMJ (November 16) (Pocket)
Harper dealt with the injury all last year, which prevented him from throwing and limited him to primarily designated hitter duties. It didn’t slow him down at the plate, as he batted .286/.364/.514 with 18 home runs in 99 games. He raised his production to a new level in October, hitting .349/.414/.746 with six home runs in 17 games.
— Sports Illustrated (November 25) (Pocket)
Author:article author:Arab NewsThu, 2022-11-24 09:33 RIYADH: Doctors in Riyadh have successfully operated on Saudi footballer Yasser Al-Shahrani after he sustained serious injuries during Kingdom’s historic match against Argentina at the World Cup in Qatar. Al-Shahrani was airlifted from Doha’s Hamad Medical City to Riyadh on Wednesday morning for treatment after he was involved in a horrific collision with Green Falcons keeper Mohammed al-Owais. He suffered a fractured jaw and to the left of his face. He was also suffering internal bleeding that needed rapid surgical intervention.Main category:SportFootballTags:World Cup 2022
— Arab News (November 25) (Pocket)
Saudi's Al-Shahrani undergoes surgery, doubtful for rest of World CupReutersLionel Messi fronts up to defeat as Saudi fans take over Doha after World Cup upsetCNNWorld Cup or NCAA basketball tournament? Chaos rules with major upsets
— Reuters (November 25) (Pocket)
The update came two years after Sinbad had an ischemic stroke after a blood clot traveled from his heart to his brain, his family said. After an initially "very promising" prognosis, however, he developed another blood clot the next day. Soon after he had to undergo a second surgery, his brain started to swell, and as doctors attempted to relieve the pressure during a craniotomy, they discovered a brain bleed.
— CBS (November 24) (Pocket)
Cardinals' Albert Pujols and Astros' Justin Verlander named MLB Comeback Players of the Year for 2022 - CBS Sports
The award goes annually to the player in each league who enjoys success during the season in question despite being confronted with obstacles of some kind. In Verlander's case, he missed the entire 2021 season after undergoing Tommy John surgery. Coming off the major procedure and at the age of 39, Verlander went 18-4 for the eventual World Series champs with an MLB-best ERA of 1.75 and a K/BB ratio of 6.38. Days prior to winning Comeback Player of the Year for 2022, Verlander won the AL Cy Young award for the third time in his career. He's now one of the most coveted arms on the free agent market and will join the rare class of ...
— CBS Sports (November 23) (Pocket)
Ryuichi Sakamoto has announced details of a new solo album. 12, Sakamoto's 15th solo album, will be released via Milan Records on January 17. The album is comprised of musical ideas and sketches recorded between 2021-2022 while Sakamoto battled cancer. He first announced his throat cancer diagnosis in January last year, revealing that he was due to undergo surgery. It was the second time Sakamoto had been diagnosed with the disease, he had been in remission since 2015.
— The Fader (November 22) (Pocket)
How long will surgery keep Bryce Harper out of Phillies' lineup in 2023?NBC SportsPhillies' Bryce Harper set for elbow surgery; 2023 timeline unclearESPNBryce Harper To Undergo Elbow Surgery Next WeekMLB Trade RumorsBryce Harper to have UCL surgery next week, Phillies unsure when he'll return in 2023Yahoo SportsHarper questions continue
— NBC Sports (November 17) (Pocket)
2022 © Helium Trades
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.